A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults
Clinical trial NCT05114265 · COMPLETED
Trial details
- NCT number
- NCT05114265
- Sponsor
- Kures, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2022-10-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.